ArticleScientific reports2021

A randomised, non-inferiority study of chloroprocaine 2% and ropivacaine 0.75% in ultrasound-guided axillary block.

Irene Sulyok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.